|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Alpha-thrombin (hirugen) complexed with na-(n,n-dimethylcarbamoyl)- alpha-azalysine
|
|
Structure:
|
 |
Alpha-thrombin. Chain: l. Alpha-thrombin. Chain: h. Hirudin i. Chain: i
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Tissue: plasma. Hirudo medicinalis. Medicinal leech. Organism_taxid: 6421. Tissue: plasma
|
|
Biol. unit:
|
 |
Not given
|
|
Resolution:
|
 |
|
|
Authors:
|
 |
M.Nardini,A.Pesce,M.Rizzi,E.Casale,R.Ferraccioli,G.Balliano,P.Milla, P.Ascenzi,M.Bolognesi
|
Key ref:
|
 |
M.Nardini
et al.
(1996).
Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
J Mol Biol,
258,
851-859.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
26-Mar-96
|
Release date:
|
08-Nov-96
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains L, H:
E.C.3.4.21.5
- thrombin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Gly; activates fibrinogen to fibrin and releases fibrinopeptide A and B.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
258:851-859
(1996)
|
|
PubMed id:
|
|
|
|
|
| |
|
Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
|
|
M.Nardini,
A.Pesce,
M.Rizzi,
E.Casale,
R.Ferraccioli,
G.Balliano,
P.Milla,
P.Ascenzi,
M.Bolognesi.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Kinetics for the hydrolysis of the chromogenic active site titrant N
alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester
(Dmc-azaLys-ONp) catalyzed by bovine beta-trypsin, bovine alpha-thrombin, human
alpha-thrombin, human Lys77-plasmin, human urinary kallikrein, the M(r) 33,000
and M(r) 54,000 species of human urokinase, as well as by porcine pancreatic
beta-kallikrein-A and B have been obtained between pH 6.0 and 8.0, at 21.0
degrees C. Moreover, the three dimensional structure of the human
alpha-thrombin-(hirugen).Dmc-azaLys acyl.enzyme complex has been analyzed and
refined by X-ray crystallography at 2.0 A resolution (R-factor = 0.168). As
observed for bovine beta-trypsin, the acylating inhibitor molecule is covalently
bound to the Ser195 catalytic residue, filling the human alpha-thrombin S1
primary specificity subsite with its lysyl side-group. However, the carbonyl
group of the scissile human alpha-thrombin.Dmc-azaLys acyl bond does not occupy
properly the oxyanion binding hole. At variance from the bovine
beta-trypsin.Dmc-azaLys acyl.enzyme structure, a second, not covalently bound,
inhibitor molecule, partly shielded by the 60-insertion loop of human
alpha-thrombin, is contacting the enzyme "aryl-binding site".
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Chemical structure of
Dmc-azaLys-ONp. The O-8 and
O-12 atoms of the active site titrant,
relevant for the discussion, have
been labeled.
|
 |
Figure 2.
Figure 2. A, Time-course of p-nitrophenol release during the human a-thrombin (trace a) and bovine a-thrombin (trace
b) catalyzed hydrolysis of Dmc-azaLys-ONp at pH 6.2 and 21.0°C, with [S0]e5[E0 ]. Kinetics of p-nitrophenol release
were obtained at [Dmc-azaLys-ONp] = 5.0 × 10
2
mM; [E0] was 5.0 mM. The total amplitude of the time-course of
p-nitrophenol release (p; see equation (2)) corresponds to an absorbance change of 2.6 × 10
-2
(i.e. to an active enzyme
concentration of 5.0 mM). Values of the apparent first-order rate constant of the time-course of p-nitrophenol release (k;
s
-1
) are 5.45 s
-1
(trace a) and 3.65 s
-1
(trace b). B, Effect of the Dmc-azaLys-ONp concentration on the apparent first-order
rate constant (k) for the human a-thrombin (open circles) and bovine a-thrombin (filled circles) catalyzed hydrolysis
of the active site titrant at pH 6.2 and 21.0°C, with [S0 ]e5 [E0 ]. The continuous lines, representing the best theoretical
curves fitting the data, were calculated according to equation (3) with values of KS and k+2 given in Table 1. An average
S.E. of 27% was evaluated as the standard deviation for values of KS and k+2 . The arrows indicate the asymptotic values
of k that correspond to k+2 when [S0 ]>KS (see equation (3)). For further details, see the text.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1996,
258,
851-859)
copyright 1996.
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.C.Liu,
E.Brustad,
W.Liu,
and
P.G.Schultz
(2007).
Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin.
|
| |
J Am Chem Soc,
129,
10648-10649.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.J.McFarland,
and
C.Beeson
(2002).
Binding interactions between peptides and proteins of the class II major histocompatibility complex.
|
| |
Med Res Rev,
22,
168-203.
|
 |
|
|
|
|
 |
P.Ascenzi,
G.Balliano,
C.Gallina,
F.Polticelli,
and
M.Bolognesi
(2000).
Serine proteinase inhibition by the active site titrant N alpha-(N, N-dimethylcarbamoyl)-alpha-azaornithine p-nitrophenyl ester. A comparative study.
|
| |
Eur J Biochem,
267,
1239-1246.
|
 |
|
|
|
|
 |
A.Lombardi,
G.De Simone,
S.Galdiero,
N.Staiano,
F.Nastri,
and
V.Pavone
(1999).
From natural to synthetic multisite thrombin inhibitors.
|
| |
Biopolymers,
51,
19-39.
|
 |
|
|
|
|
 |
G.De Simone,
A.Lombardi,
S.Galdiero,
F.Nastri,
R.Della Morte,
N.Staiano,
C.Pedone,
M.Bolognesi,
and
V.Pavone
(1998).
Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex.
|
| |
Protein Sci,
7,
243-253.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Cortesi,
P.Ascenzi,
M.Colasanti,
T.Persichini,
G.Venturini,
M.Bolognesi,
A.Pesce,
C.Nastruzzi,
and
E.Menegatti
(1998).
Cross-enzyme inhibition by gabexate mesylate: formulation and reactivity study.
|
| |
J Pharm Sci,
87,
1335-1340.
|
 |
|
|
|
|
 |
S.Tada,
and
J.J.Blow
(1998).
The replication licensing system.
|
| |
Biol Chem,
379,
941-949.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |